Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2001-02-27
2008-10-21
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S013800, C514S014800, C514S015800
Reexamination Certificate
active
07439228
ABSTRACT:
The present invention provides a cytotoxic 7 to 25-mer peptide with three or more catonic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them, and their use as medicaments, particularly as antibacterial or antitumor agents.
REFERENCES:
patent: 4476116 (1984-10-01), Anik
patent: 5073542 (1991-12-01), Zasloff
patent: 5141851 (1992-08-01), Brown et al.
patent: 5304633 (1994-04-01), Tomita et al.
patent: 5411942 (1995-05-01), Widner et al.
patent: 5428016 (1995-06-01), Tomita et al.
patent: 5565425 (1996-10-01), Yamamoto et al.
patent: 5593866 (1997-01-01), Hancock et al.
patent: 5789542 (1998-08-01), McLaughlin et al.
patent: 2003/0022821 (2003-01-01), Svenden et al.
patent: 0 629 347 (1997-07-01), None
patent: WO92/22317 (1992-12-01), None
patent: WO93/24138 (1993-12-01), None
patent: WO94/12206 (1994-06-01), None
patent: WO94/01451 (1995-01-01), None
patent: WO96/40768 (1996-12-01), None
patent: WO96/40770 (1996-12-01), None
patent: WO98/06425 (1998-02-01), None
patent: WO98/06860 (1998-02-01), None
patent: WO98/40091 (1998-09-01), None
patent: WO98/40401 (1998-09-01), None
patent: WO00/12542 (2000-03-01), None
European Patent Application Publication No. 0 510 912 A1m Oct. 28, 1992.
European Patent Application Publication No. 0 299 828 A1, Jan. 18, 1989.
Andreu et al. (1985) Biochemistry 24:1683-1688.
Bellamy et al. (1992) Journal of Applied Bacteriology 73:472-479.
Bellamy et al. (1992) Biochimica et Biophysica Acta 1121:130-136.
Bessalle et al. (1993) J. Med. Chem. 36:1203-1209.
Blondelle et al. (1992) Biochemistry 31:12688-12694.
Boman (1995) Ann. Rev. Immunol. 13:61-92.
Chapple et al. (1998) Infection and Immunity 66:2434-2440.
Chen et al. (1988) FEB 236:462-466.
Cruciani et al. (1991) Proc. Natl Acad. Sci. USA 88:3792-3796.
Hancock et al. (1995) Advances in Microbial Physiol. 37:135-175.
Juretic et al. (1989) FEB 249:219-223.
Kang et al. (1996) Int. J. Peptide Protein Res. 48:357-363.
Ludtke et al. (1996) Biochemistry 35:13723-13728.
Ranjalahy-Rasoloarijao et al. (1989) Int. J. Peptide Protein Res. 33:273-280.
Selsted et al. (1992) J. Biol. Chem. 267:4292-4295.
Stierandova et al. (1994) Int. J. Peptide Protein Res. 43:31-38.
Tomita et al. (1991) J. Fairy Sci. 74:4137-4142.
Vorland et al. (1999) APMIS. 107:971-981.
Wieprecht et al. (1997) FEBS Letters 417:135-140.
Yoo et al. (1997) Japanese Journal of Cancer Research 88:184-190.
Zasloff et al. (1988) Proc. Natl. Acad. Sci. USA 85:910-913.
Rekdal Øystein
Sveinbjørnsson Baldur
Svendsen John Sigurd
Vorland Lars
Crowell & Moring LLP
Lytix Biopharma AS
Teller Roy
Tsang Cecilia
LandOfFree
Bioactive peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990770